Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EY5420 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Anaphylactic reaction, Body temperature, Choking sensation, Dysphagia, Oxygen saturation, Vital signs measurement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Current Illness: Rhinitis allergic
Diagnostic Lab Data: Test Date: 20210603; Test Name: body temperature; Result Unstructured Data: Test Result:36.4 Centigrade; Comments: before vaccination; Test Date: 20210603; Test Name: oxygen saturation; Test Result: 99 %; Test Date: 20210603; Test Name: vital; Result Unstructured Data: Test Result:Normal
CDC 'Split Type': JPPFIZER INC2021655925
Write-up: slight Anaphylaxis; swallowing difficult; Pharynx strangled sensation of; This is a spontaneous report from a contactable physician received from the Regulatory Authority (RA). Regulatory authority report number is v21111778. The patient was 51-year and 9-month female. Body temperature before vaccination was 36.4 degrees Centigrade. The patient had relevant medical history of rhinitis allergic and was receiving medical treatment by oral administration. On 03Jun2021 at 10:15 (the day of vaccination), the patient received the second dose of bnt162b2 (COMIRNATY, Lot number EY5420 and Expiration date 31Aug2021) at the age of 51-year-old. On 03Jun2021, the results of the events were recovered. The details of event were as follows: On 03Jun2021 (the day of vaccination), 30 minutes after the vaccination, the patient experienced swallowing difficult and pharynx strangled sensations of, and the symptoms became progressively stronger. No breathing difficulty, vital signs normal including oxygen saturation (99%). But the symptoms were still ongoing, so the patient received BOSMIN 0.15mg intramuscular injection. After the injection, the symptoms were clearly improved. The reporter classified the event as non-serious and assessed the causality between the event and the vaccines as related. The reporter commented as follows: it was considered as slight anaphylaxis.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166